AI-generated analysis. Always verify with the original filing.
Totaligent, Inc. entered into an Extension Amendment to its Binding Letter of Intent dated February 11, 2026, with Aetherium Medical, extending the target dates for negotiating definitive agreements and closing the proposed acqui-hire transaction from March 5, 2026, to April 10, 2026. This allows additional time for due diligence and negotiations while extending the binding exclusivity period through April 10, 2026.
Event Type
Disclosure
Mandatory
Variant
8-K
Entry into a Material Definitive Agreement. On March 4, 2026, Totaligent, Inc. (the “Company”) entered into an Extension Amendment (the “Amendment”) to the Bind
Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 10.1 Extension Amendment to Binding Letter of Intent, dated March 20, 2026, between Tota
Material Agreement